These oral disease-modifying therapies are approved for treating relapsing MS:
- Fingolimod (Gilenya).
People with heart disorders or related conditions can't use fingolimod and you must take the first dose in a clinic under medical supervision. It also requires monitoring of vision because of a risk of buildup of fluid in the macula.
- Teriflunomide (Aubagio).
Possible side effects include a headache, diarrhea, nausea, elevation in liver enzymes and hair thinning. Teriflunomide can be harmful to a developing fetus. People with liver conditions also shouldn't use it.
- Dimethyl fumarate (Tecfidera).
Common side effects include flushing and gastrointestinal problems, such as diarrhea and nausea.
Key words: multiple sclerosis oral medication; multiple sclerosis oral pill; oral pill multiple sclerosis; oral treatment multiple sclerosis.